These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6539448)

  • 1. Irreversible neurologic complications of metrizamide myelography.
    Meador K; Hamilton WJ; El Gammal TA; Demetropoulos KC; Nichols FT
    Neurology; 1984 Jun; 34(6):817-21. PubMed ID: 6539448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic complications in diabetics after metrizamide lumbar myelography.
    Steiner E; Simon JH; Ekholm SE; Erickson J; Kido DK; Okawara S
    AJR Am J Roentgenol; 1986 May; 146(5):1057-60. PubMed ID: 3485900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelography with metrizamide--an analysis of the complications encountered in cervical, thoracic and lumbar myelography.
    McCormick CC; ApSimon HT; Chakera TM
    Aust N Z J Med; 1981 Dec; 11(6):645-50. PubMed ID: 6949540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalized motor seizure following metrizamide cisternography.
    Saltiel E; Adelman DC; Ellis JC; Young WI
    Drug Intell Clin Pharm; 1984 Nov; 18(11):894-6. PubMed ID: 6437782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of metrizamide myelography.
    Killebrew K; Whaley RA; Hayward JN; Scatliff JH
    Arch Neurol; 1983 Feb; 40(2):78-80. PubMed ID: 6824454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious neurological complications of metrizamide myelography. Report of eight cases.
    Picard L; Vespignani H; Vieux-Rochat P; Moret C; L'espérance G; Montaut J; Wéber M; Roland J
    J Neuroradiol; 1979; 6(1):3-14. PubMed ID: 479926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effects of metrizamide (Amipaque) cervical myelography (author's transl)].
    Okada K; Nishimatsu T; Wada H; Komatsu T
    No Shinkei Geka; 1982 May; 10(5):511-8. PubMed ID: 7110515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Radiology; 1984 Jun; 151(3):665-70. PubMed ID: 6371890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metrizamide with other myelographic agents.
    Bentson JR
    Clin Orthop Relat Res; 1977; (127):111-9. PubMed ID: 912965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of dehydration on the side effects of metrizamide myelography.
    Eldevik OP; Nakken KO; Haughton VM
    Radiology; 1978 Dec; 129(3):715-6. PubMed ID: 152937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asterixis following metrizamide myelography.
    Rubin B; Horowitz G; Katz RI
    Arch Neurol; 1980 Aug; 37(8):522. PubMed ID: 7417045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients.
    Sackett JF; Strother CM; Quaglieri CE; Javid MJ; Levin AB; Duff TA
    Radiology; 1977 Jun; 123(3):779-82. PubMed ID: 860047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbar myelography with metrizamide-a new non-ionic contrast medium.
    Grainger RG
    Br J Radiol; 1976 Dec; 49(588):996-1003. PubMed ID: 793673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metrizamide myelography for cervical spinal cord injuries.
    Leo JS; Bergeron RT; Kricheff II; Benjamin MV
    Radiology; 1978 Dec; 129(3):707-11. PubMed ID: 725046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of metrizamide for neuroradiology in chilren.
    Swick HM; Sty JR; Haughton VM
    Ann Neurol; 1978 May; 3(5):409-15. PubMed ID: 310277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of levomepromazine on EEG and on clinical side effects after lumbar myelography with metrizamide.
    Standnes B; Oftedal SI; Weber H
    Acta Radiol Diagn (Stockh); 1982; 23(2):111-4. PubMed ID: 7090846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbar myelography today. Experience with metrizamide, a water-soluble, non-ionic contrast medium.
    Sage MR; Benness GT; Perrett LV; Mansfield J
    Med J Aust; 1981 Feb; 1(4):175-6. PubMed ID: 7015091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG changes 24 hours after myelography with metrizamide.
    Koshino Y; Isaki K; Kihara Y; Yamaguchi N; Yugami H; Yamamoto S; Baba H; Umeda S; Shima I; Nomura S
    Folia Psychiatr Neurol Jpn; 1985; 39(1):59-70. PubMed ID: 4054762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of adverse effects following metrizamide myelography in nonambulatory and ambulatory patients.
    Sykes RH; Wasenaar W; Clark P
    Radiology; 1981 Mar; 138(3):625-7. PubMed ID: 7465839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of headache following various techniques of metrizamide myelography.
    Rolfe EB; Maguire PD
    Br J Radiol; 1980 Sep; 53(633):840-4. PubMed ID: 7437703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.